### **1) Header**

*   **Company:** Carriage Services, Inc.
*   **Ticker:** CSV
*   **Reporting Currency:** USD
*   **Date of Analysis:** August 22, 2025
*   **Primary Sources Reviewed:**
    *   Form 10-K for the fiscal year ended December 31, 2024 (filed with SEC on February 24, 2025)
    *   Form 10-Q for the quarterly period ended September 30, 2024 (filed with SEC on October 25, 2024)
    *   Form 10-Q for the quarterly period ended March 31, 2025 (filed with SEC on April 25, 2025)
    *   Form 10-Q for the quarterly period ended June 30, 2025 (filed with SEC on July 31, 2025)
    *   OpenInsider trade data for CSV, reviewed on August 22, 2025
    *   List of available earnings call transcripts, reviewed on August 22, 2025

### **2) Top 3 Prioritized Catalysts (Summary Table)**

| Catalyst Title | Type | Timing Window | Impact | Probability | One-Line Evidence Citation |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Accelerated Deleveraging from Asset Divestitures** | Financial / Corporate Action | 0–9 months | Medium (10–25%) | 90% | Company sold ~$16M in assets in Q1 2025 and another $5.5M in July, using proceeds to pay down credit facility. |
| **Preneed Funeral Sales Growth via Strategic Partnership** | Operational / Partnership | 6–18 months | Medium (10-20%) | 75% | Partnership projected to double commission income in 2025 and drive 20% Y/Y preneed sales growth over 5 years. |
| **Execution of Share Repurchase Program** | Corporate Action | 0–12 months | Small (5–15%) | 40% | $48.9 million remains authorized for share repurchases as of March 31, 2025. |

### **3) Near-Term Catalysts (0–12 months)**

**1. Catalyst Title: Accelerated Deleveraging from Asset Divestitures**
*   **Type:** Financial / Corporate Action
*   **Description (1–2 sentences):** The company is actively divesting non-core assets and using the proceeds to aggressively pay down its revolving credit facility. In the first half of 2025, the company sold multiple funeral homes and cemeteries for proceeds exceeding $21 million and made significant debt repayments.
*   **Mechanism:** Reducing debt on the balance sheet lowers interest expense, which directly increases net income and earnings per share (EPS). A stronger balance sheet and improved credit metrics (e.g., lower leverage ratio) can lead to a valuation re-rating by the market, as financial risk decreases.
*   **Timing:** August 2025 – May 2026. Divestitures are ongoing, with a sale occurring as recently as July 2025.
*   **Quantification:**
    *   **Low Case:** No further material divestitures. Debt paydown continues from operating cash flow only.
    *   **Base Case:** An additional $10–$15 million in assets are sold over the next 12 months.
        *   Debt Reduction: ~$12.5M
        *   Assumed Interest Rate on Credit Facility (SOFR + 2.5%): ~8.0% (based on current rates)
        *   Annual Interest Expense Savings: $12.5M \* 8.0% = $1.0M
        *   Net Income Impact (after ~25% tax): $1.0M \* (1 - 0.25) = $0.75M
        *   EPS Impact (15.7M shares outstanding): $0.75M / 15.7M = ~$0.05/share increase.
    *   **High Case:** Over $20 million in additional divestitures, leading to more significant debt reduction.
*   **Estimated Price Impact:** 10–25% (Medium). The impact comes from both the direct EPS accretion and a potential multiple expansion as the company moves toward its target leverage ratios.
*   **Probability / Confidence (0–100%):** 90%. The company has demonstrated a clear pattern of divestiture and debt paydown in the first half of 2025, and management has stated this is a capital allocation priority.
*   **Key Dependencies / Conditions:** Successful closing of planned divestitures at reasonable valuations.
*   **Monitoring Triggers / KPIs:**
    *   Press releases or 8-K filings announcing asset sales.
    *   Quarterly balance sheets (Form 10-Q) showing reductions in "Credit facility" borrowings.
    *   Quarterly income statements showing a reduction in "Interest expense."
*   **Anti-Catalysts / Risks:**
    *   Inability to find buyers for non-core assets.
    *   Divestitures completed at prices below carrying value, resulting in accounting losses.
    *   Slowing operating cash flow, which would reduce the ability to pay down debt.
*   **Suggested Investor Action:** Watch. Monitor upcoming quarterly reports for continued execution on debt reduction to confirm the thesis.

---

**2. Catalyst Title: Execution of Share Repurchase Program**
*   **Type:** Corporate Action
*   **Description (1–2 sentences):** The company has an authorized share repurchase program with $48.9 million remaining as of March 31, 2025. With the balance sheet improving from asset sales, management may deploy this capital to repurchase shares, which would be accretive to EPS.
*   **Mechanism:** Share repurchases reduce the number of shares outstanding, which increases EPS for a given level of net income. This action signals management's belief that the stock is undervalued and is a tax-efficient way to return capital to shareholders.
*   **Timing:** September 2025 – August 2026. Most likely to commence after significant progress has been made on deleveraging.
*   **Quantification:**
    *   **Low Case:** No repurchases are made as debt reduction remains the sole priority.
    *   **Base Case:** Company utilizes $20 million of the authorization over 12 months.
        *   Assumed Average Share Price: $35.00
        *   Shares Repurchased: $20M / $35.00 = ~571,400 shares
        *   Shares Outstanding (as of July 31, 2025): 15,698,487
        *   Percentage Reduction in Shares: 571,400 / 15,698,487 = 3.6%
        *   EPS Accretion: Directly proportional, a ~3.6% increase.
    *   **High Case:** Full $48.9 million authorization is used.
*   **Estimated Price Impact:** 5–15% (Small). The impact is primarily from the EPS accretion and improved investor sentiment.
*   **Probability / Confidence (0–100%):** 40%. The company has not repurchased shares in 2024 or the first half of 2025, prioritizing debt paydown. This makes the timing and likelihood uncertain, despite the large authorization.
*   **Key Dependencies / Conditions:** Company must achieve leverage ratio targets that provide flexibility for share buybacks under its credit facility covenants.
*   **Monitoring Triggers / KPIs:**
    *   Quarterly cash flow statements (Form 10-Q) showing cash used for "Purchase of treasury stock."
    *   Item 5 in the Form 10-K detailing issuer purchases of equity securities.
    *   Company press releases announcing repurchase activity.
*   **Anti-Catalysts / Risks:**
    *   Management continues to prioritize debt repayment exclusively.
    *   A significant acquisition opportunity arises, diverting capital away from repurchases.
    *   Stock price increases significantly, making repurchases less attractive.
*   **Suggested Investor Action:** Watch. This is a potential but unconfirmed catalyst. Positive signals on debt reduction would increase the probability of this catalyst occurring.

### **4) Long-Term Catalysts (12–60 months)**

**1. Catalyst Title: Preneed Funeral Sales Growth via Strategic Partnership**
*   **Type:** Operational / Partnership
*   **Description (1–2 sentences):** In 2023, the company entered an exclusive partnership with a national insurance provider to market and sell prearranged funeral services. Management projects this will double commission income in 2025 and drive a 20% year-over-year growth in preneed funeral sales over the next five years.
*   **Mechanism:** Successful execution will grow the backlog of future high-margin revenue, increase near-term cash flow from commission income, and build market share. As these preneed contracts mature and are serviced, they will provide a predictable, growing, and high-margin revenue stream, leading to higher long-term earnings and free cash flow.
*   **Timing:** August 2026 – August 2030. This is a multi-year growth initiative.
*   **Quantification (Illustrative 3-year impact):**
    *   **Low Case:** Preneed sales grow at 5% annually, below target. Minimal impact on valuation.
    *   **Base Case:** Achieves 15% annual growth in preneed funeral contracts sold.
        *   2024 Preneed Contracts Sold: 10,750
        *   Inference (Year 3 Contracts Sold): 10,750 \* (1.15^3) = ~16,350 contracts
        *   This increase would significantly grow the backlog of future revenue (102,799 contracts at YE 2024). The direct impact is on commission income (Other Revenue) and long-term deferred revenue.
    *   **High Case:** Achieves the 20% annual growth target, leading to a substantial increase in the revenue backlog and commission income.
*   **Estimated Price Impact:** 15–30% (Medium). Growth in high-margin, predictable revenue streams should warrant a higher valuation multiple over time.
*   **Probability / Confidence (0–100%):** 75%. Management has provided specific, quantified targets for this strategic initiative, indicating a high degree of focus. Initial results have been positive.
*   **Key Dependencies / Conditions:** Success of the national insurance partner's sales efforts; consumer demand for preneed products.
*   **Monitoring Triggers / KPIs:**
    *   "Other revenue" line in quarterly income statements (reflects commission income).
    *   "Deferred preneed funeral revenue" on the balance sheet.
    *   Management commentary on preneed sales volume in quarterly reports and earnings calls.
*   **Anti-Catalysts / Risks:**
    *   The insurance partner fails to meet sales targets.
    *   Changes in regulations governing preneed sales.
    *   Economic downturn reduces consumer demand for preneed products.
*   **Suggested Investor Action:** Buy. This appears to be a well-defined, multi-year growth driver that may not be fully reflected in the current share price.

### **5) Prioritization & Scoring Table**

| ID | Title | Type | Timing | Impact Score (1-5) | Probability Score (1-5) | Expected Impact (% price range) | Weighted Score |
| :-- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | Accelerated Deleveraging from Asset Divestitures | Financial | Near | 3 | 5 | 10–25% | 15.0 |
| 2 | Preneed Funeral Sales Growth via Strategic Partnership | Operational | Long | 4 | 4 | 15–30% | 16.0 |
| 3 | Execution of Share Repurchase Program | Corporate | Near | 2 | 2 | 5–15% | 4.0 |

*(Sorted by Weighted Score, Top 3 shown)*

### **6) Timeline / Gantt (Top Catalysts)**

| Catalyst | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026+ |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Deleveraging from Divestitures** | ■■■■■■ | ■■■■■■ | ■■■■■□ | □□□□□□ | □□□□□□ |
| **Preneed Sales Growth** | ■■■■■■ | ■■■■■■ | ■■■■■■ | ■■■■■■ | Ongoing |
| **Share Repurchase Program** | □□□■■■ | □□■■■■ | ■■■■■■ | ■■■■■■ | Possible |

*(■ = Expected window, □ = Possible but less likely)*

### **7) Valuation Sensitivity Examples**

**1. Accelerated Deleveraging Catalyst:**
*   **Scenario:** Base case of $1.0M in annual interest expense savings from divestiture-funded debt paydown.
*   **Formula:** Increase in Net Income = (Interest Savings) \* (1 - Tax Rate)
*   **Calculation (Cited Inputs):**
    *   Interest Savings: $1,000,000
    *   Tax Rate (Inferred from 2024 effective rate): ~34%
    *   Increase in Net Income: $1,000,000 \* (1 - 0.34) = $660,000
    *   Increase in EPS: $660,000 / 15,698,487 shares = **$0.04 EPS**
*   **Valuation Impact:** At a 15x P/E multiple, this adds **$0.60 to the share price**. This excludes any positive re-rating from the improved balance sheet.

**2. Preneed Funeral Sales Growth Catalyst:**
*   **Scenario:** Commission income doubles in 2025 as projected by management.
*   **Formula:** Incremental Revenue = (2024 Commission Revenue)
*   **Calculation (Inference from "Other Revenue"):**
    *   "Other Revenue" in the Funeral segment (mostly commissions/trust earnings) was $14.06M in 2024.
    *   Assuming commission income is ~50% of this, or ~$7M.
    *   Incremental Pre-Tax Income: ~$7M (as commissions are very high margin).
    *   Incremental Net Income: $7M \* (1 - 0.34) = $4.62M
    *   Incremental EPS: $4.62M / 15,698,487 shares = **$0.29 EPS**
*   **Valuation Impact:** At a 15x P/E multiple, this could add **$4.35 to the share price** over the next 12-18 months as results are reported.

### **8) Net Catalysts Balance & Short-Term Market Signal**

The balance of near-term catalysts for Carriage Services appears positive. The company's demonstrated commitment to divesting non-core assets and using the proceeds for rapid debt reduction is a clear, tangible driver of value. This deleveraging strengthens the balance sheet and directly improves EPS by reducing interest expense. While the timing of the share repurchase program remains uncertain, the significant authorization provides a secondary avenue for capital return. These positive financial catalysts create a favorable short-term market signal, suggesting a potential re-rating as the company's risk profile improves and earnings increase.

### **9) Evidence Matrix**

| Citation | Claim(s) / Field(s) Supported |
| :--- | :--- |
| **Form 10-K (Dec 31, 2024)** | Share repurchase authorization amount; 2024 dividend payments; Details of strategic partnership and preneed growth targets; 2024 divestiture details; Total debt; Effective tax rate; 2024 preneed contracts sold; Total preneed backlog. |
| **Form 10-Q (Sep 30, 2024)** | Confirmation of no share repurchases in Q1-Q3 2024; Shares outstanding as of Oct 2024. |
| **Form 10-Q (Mar 31, 2025)** | Q1 2025 divestiture proceeds and debt repayment; Confirmation of no share repurchases; Updated share repurchase authorization. |
| **Form 10-Q (June 30, 2025)** | July 2025 divestiture details; H1 2025 debt repayment; Most recent shares outstanding count. |
| **OpenInsider Data (Aug 22, 2025)** | Details of insider purchases by Director Fargason and CEO Quezada in 2024 and sales by executives in 2025. |

### **10) Three Highest-Risk Events That Could Negate All Catalysts**

1.  **Decline in Death Rates or Unfavorable Consumer Preference Shifts:** A significant, unexpected decline in death rates in key markets or an accelerated shift to lower-revenue cremations without the successful upselling of additional services could reduce revenue and profitability, undermining growth and deleveraging efforts.
2.  **Failed Integration of Acquisitions or Inability to Execute Divestitures:** If recently acquired businesses underperform or if the company cannot execute planned divestitures at fair prices, the expected financial benefits will not materialize, and management's credibility could be damaged.
3.  **Adverse Interest Rate Fluctuations:** As a significant portion of the company's debt is variable-rate, a sharp increase in interest rates could offset the benefits of debt reduction and pressure margins, limiting financial flexibility for shareholder returns.

### **11) Final Recommendation Paragraph (2–3 sentences)**

Based on the analysis, the recommendation is a **Buy** for Carriage Services. The primary catalyst is the company's clear and executed strategy of divesting non-core assets to rapidly deleverage, which is creating tangible value by reducing risk and interest expense. A conservative estimate suggests a potential upside of 15–30% over the next 12-24 months, driven by both near-term debt reduction and the initial results of the long-term preneed sales partnership. The single most important indicator to monitor is the "Credit facility" liability on the quarterly balance sheet, as continued reduction will validate the core thesis.

catalyst score is 3 / 5